Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
0.3186
+0.0053 (1.69%)
At close: Jun 6, 2025, 4:00 PM
0.3100
-0.0086 (-2.70%)
After-hours: Jun 6, 2025, 7:57 PM EDT
Ovid Therapeutics Employees
Ovid Therapeutics had 23 employees as of December 31, 2024. The number of employees decreased by 17 or -42.50% compared to the previous year.
Employees
23
Change (1Y)
-17
Growth (1Y)
-42.50%
Revenue / Employee
$23,826
Profits / Employee
-$1,058,217
Market Cap
22.66M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
OVID News
- 25 days ago - Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - Ovid Therapeutics Reports Business Updates and Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 3 months ago - Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos to Board of Directors - GlobeNewsWire
- 3 months ago - Ovid Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 4 months ago - Ovid Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 9 months ago - Meg Alexander Takes on Expanded Role as President and COO at Ovid Therapeutics, Strengthening Leadership for Future Growth - GlobeNewsWire
- 10 months ago - Shareholders In Ovid Therapeutics Inc Invited To Participate In Fraud Investigation With The Schall Law Firm - Accesswire
- 10 months ago - Ovid Therapeutics Inc Investors Encouraged To Join Fraud Investigation With Schall Law Firm - Accesswire